Hepatitis B and hepatitis C infection prevalence in ankylosing spondylitis patients
Open Access
- 30 September 2018
- journal article
- Published by Veritas Publications LTD in Ortadoğu Tıp Dergisi
- Vol. 10 (3) , 297-301
Abstract
Tr en Amaç : Romatizmal hastalıkların tedavisi için kullanılan ilaçların immünsupresif etkileri, hepatit B virüsü (HBV) ve hepatit C virüsü (HCV) ile karşılaşmış hastalarda reaktivasyona neden olmaktadır. Bu çalışmada ankilozan spondilitli hastalarda HBV ve HCV enfeksiyon prevalansını araştırmayı amaçladık. Gereç ve Yöntem: Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi Fizik Tedavi ve Rehabilitasyon polikliniğinde takip edilmekte olan 134 Ankilozan Spondilitli (AS) hastanın kayıtları retrospektif olarak değerlendirildi. Bulgular: Hastaların ortalama yaşı 43.0±12.0 olarak tespit edildi. %4.5’inde HBsAg pozitif olarak saptandı. Anti HBs pozitiflik oranı %22,4 olarak gözlendi. Hastaların 2’sinde (%1,5) Anti HCV pozitif bulunmuştur. 32 hastada (%23,8) izole Anti HBc IgG pozitiliği saptandı. Sonuçlar: Ankilozan Spondilit’li hastalarda HBV ve HCV enfeksiyon prevalansı daha önceki çalışmalarda bildirilen oranlara paralel iken izole Anti HBc IgG pozitifliği ise yüksektir. Aim: Immunsupressive effects of drugs used for treatment of rheumatological diseases can lead to activation of hepatitis B virus (HBV) and hepatitis C virus (HCV) in patients who came across before with these viruses. Material and Method: 134 Ankylosing Spondylitis (AS) patients who were followed in University of Health Sciences Bursa Resarch and Training Hospital Physical Treatment and Rehabilitation polyclinics were analysed retrospectively. Results: Patients avarage age was 43.0±12.0. HBsAg positivity was 4.5%. Anti HBs positivity was 22.4%. In 2 patients ( 1.5%) Anti HCV was positive. In 32 patients (23.8%) isolated Anti HBc IgG positivity was present. Conclusion: HBV and HCV infection prevalance in Ankylosing Spondylitis patients was parallel to previous literature whereas isolated Anti HBc IgG positivity rate was higher.Keywords
This publication has 13 references indexed in Scilit:
- Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide studyEuropean Journal of Rheumatology, 2019
- İzole Anti-HBc IgG Pozitif Olan Olgularda Hepatit B Aşılamasına Karşı Gelişen Antikor YanıtıViral Hepatitis Journal, 2012
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicityVaccine, 2012
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Low frequency of HLA-B27 in ankylosing spondylitis patients from TurkeyJoint Bone Spine, 2008
- Ankylosing spondylitisThe Lancet, 2007
- Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesAnnals of the Rheumatic Diseases, 2006
- Trends in Hepatitis B and Hepatitis C Virus among Blood Donors over 16 Years in TurkeyEuropean Journal of Epidemiology, 2006
- Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin.Annals of the Rheumatic Diseases, 1991
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984